News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lehrer-Graiwer Joshua
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/23/2023 |
4
| Lehrer-Graiwer Joshua (PRESIDENT AND CEO) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Granted 600,000 options to buy
@ $2.18, valued at
$1.3M
|
|
| 02/18/2022 |
4
| Lehrer-Graiwer Joshua (PRESIDENT AND CEO) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Granted 650,000 options to buy
@ $11.02, valued at
$7.2M
|
|
| 07/01/2021 |
4
| Lehrer-Graiwer Joshua (PRESIDENT AND CEO) has filed a Form 4 on Graphite Bio, Inc.|
Txns:
| Exercised 374,013 shares
@ $0.3, valued at
$112.2k
Converted 8,126 shares
@ $0
Granted 374,013 options to buy
@ $0
Exercised 374,013 options to buy
@ $0
Granted 19,763 preferred shares
@ $5.06, valued at
$100k
Granted 795,196 options to buy
@ $0
Granted 340,798 options to buy
@ $0
Converted 19,763 preferred shares
@ $0 |
|
| 03/09/2020 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 1,138 shares
@ $65.3, valued at
$74.3k
Sold 938 shares
@ $59.9, valued at
$56.2k
Exercised 938 options to buy
@ $19.89, valued at
$18.7k
|
|
| 03/04/2020 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 612 shares
@ $63.96, valued at
$39.1k
Exercised 1,750 restricted stock units
@ $0 |
|
| 02/20/2020 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 1,313 shares
@ $69.71, valued at
$91.5k
Exercised 1,313 options to buy
@ $26.9, valued at
$35.3k
|
|
| 02/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Granted 579 shares
@ $36.68, valued at
$21.2k
Paid exercise price by delivering 2,163 shares
@ $65.26, valued at
$141.2k
Sold 2,188 shares
@ $62.81, valued at
$137.4k
Sold 1,657 shares
@ $65, valued at
$107.7k
Exercised 1,037 restricted stock units
@ $0
Exercised 2,125 restricted stock units
@ $0
Exercised 2,938 restricted stock units
@ $0
Exercised 1,657 options to buy
@ $59.6, valued at
$98.8k
Exercised 2,188 options to buy
@ $48.44, valued at
$106k
Granted 24,160 restricted stock units
@ $0
Granted 38,500 options to buy
@ $65.82, valued at
$2.5M
|
|
| 01/29/2020 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 781 shares
@ $71.15, valued at
$55.6k
Exercised 781 options to buy
@ $27.9, valued at
$21.8k
|
|
| 12/17/2019 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 1,984 shares
@ $76.88, valued at
$152.5k
Exercised 4,000 restricted stock units
@ $0 |
|
| 12/11/2019 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 937 shares
@ $78.5, valued at
$73.6k
Exercised 937 options to buy
@ $19.89, valued at
$18.6k
|
|
| 11/27/2019 |
4
| Lehrer-Graiwer Joshua (Chief Medical Officer) has filed a Form 4 on Global Blood Therapeutics, Inc.|
Txns:
| Sold 312 shares
@ $60, valued at
$18.7k
Sold 1,108 shares
@ $60, valued at
$66.5k
Sold 3,515 shares
@ $60, valued at
$210.9k
Sold 447 shares
@ $60, valued at
$26.8k
Sold 298 shares
@ $60, valued at
$17.9k
Sold 4,594 shares
@ $60, valued at
$275.6k
Sold 656 shares
@ $60, valued at
$39.4k
Sold 11,593 shares
@ $67.19, valued at
$778.9k
Exercised 312 options to buy
@ $12.95, valued at
$4k
Exercised 1,108 options to buy
@ $19.89, valued at
$22k
Exercised 3,515 options to buy
@ $27.9, valued at
$98.1k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/18/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|